Mia's Feed
Medical News & Research

Pulmonary Embolism in Children: A Growing Concern Recognized by New Research

Pulmonary Embolism in Children: A Growing Concern Recognized by New Research

Share this article

New research reveals that pulmonary embolism in children is more common than previously believed. A large study highlights the need for increased awareness and updated diagnostic criteria in pediatric care.

2 min read

Recent groundbreaking research has illuminated that pulmonary embolism (PE) in children is far more common than previously understood. Traditionally considered a rare condition in pediatric populations, emerging evidence now indicates that PE may occur as frequently in children as it does in adults, prompting a significant shift in clinical awareness and diagnostic approaches.

The pivotal study, published in the American Journal of Respiratory and Critical Care Medicine and presented at the ATS 2025 International Conference, analyzed data from over 4,000 children aged 4 to 17 presenting with symptoms suggestive of PE across 21 U.S. emergency departments. The findings revealed that approximately 6.3% of these children were diagnosed with acute pulmonary embolism, including those with isolated PE, deep vein thrombosis, or both conditions. These rates challenge previous estimates derived from retrospective studies, which suggested PE was exceedingly rare in children.

First author Dr. Jeffrey A. Kline emphasizes that PE should now be considered a differential diagnosis in adolescents with unexplained shortness of breath. The study also identified that the clinical patterns used to diagnose PE in adults are largely applicable to children, which aids in early recognition.

In terms of diagnostics, nearly 80% of the children underwent D-dimer blood testing, a marker for blood clots, followed by imaging studies such as CT pulmonary angiography, VQ scans, MRI, or venous ultrasounds to confirm the diagnosis. Importantly, the study proposes evidence-based criteria to guide clinicians in suspecting and testing for PE, aiming to reduce unnecessary radiation exposure.

This research raises critical questions: Are some children experiencing undiagnosed PE and recovering without intervention? Or are these conditions being missed, leading to long-term complications like pulmonary hypertension or even sudden death? The authors plan further multicenter studies to refine guidelines and evaluate the safety of ruling out PE without extensive testing.

This evolving understanding underscores the importance of increased vigilance and updated diagnostic protocols in pediatric care. Recognizing PE early can significantly influence treatment decisions and outcomes, highlighting a need for clinicians to consider this diagnosis more readily in symptomatic children.

Source: https://medicalxpress.com/news/2025-05-pulmonary-embolism-children-common-previously.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Initiatives to Eliminate Race-Based Bias in Lung Function Testing

Efforts are intensifying to remove race-based adjustments from lung function testing, aiming for fairer and more accurate pulmonary assessments based on environmental and social factors. leading to updates in medical guidelines and disability evaluations.

How Patient Expectations Impact the Progression of Asthma

New research shows that optimistic patient expectations can slow asthma progression, emphasizing the importance of psychological factors in disease management.

New ESC Guidelines Enhance Diagnosis and Management of Myocarditis and Pericarditis

The European Society of Cardiology has published new guidelines to improve the diagnosis and management of myocarditis and pericarditis, emphasizing early detection, advanced imaging, and multidisciplinary care to enhance patient outcomes.

Innovative Data-Driven Method Enables Early Detection of Worrying SARS-CoV-2 Variants

A new genomic surveillance platform enables scientists to identify concerning SARS-CoV-2 variants months before WHO classification, aiding early intervention and vaccine updates.